NeuroPace Statistics
Share Statistics
NeuroPace has 29.85M shares outstanding. The number of shares has increased by 11.08% in one year.
| Shares Outstanding | 29.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.49% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 14.07M |
| Failed to Deliver (FTD) Shares | 654 |
| FTD / Avg. Volume | 0.83% |
Short Selling Information
The latest short interest is 437.93K, so 1.47% of the outstanding shares have been sold short.
| Short Interest | 437.93K |
| Short % of Shares Out | 1.47% |
| Short % of Float | 3.19% |
| Short Ratio (days to cover) | 6.35 |
Valuation Ratios
The PE ratio is -8.09 and the forward PE ratio is -6.8.
| PE Ratio | -8.09 |
| Forward PE | -6.8 |
| PS Ratio | 4.07 |
| Forward PS | 3.7 |
| PB Ratio | 12.9 |
| P/FCF Ratio | -13.41 |
| PEG Ratio | n/a |
Enterprise Valuation
NeuroPace Inc. has an Enterprise Value (EV) of 320.87M.
| EV / Earnings | -9.74 |
| EV / Sales | 4.9 |
| EV / EBITDA | -14.05 |
| EV / EBIT | -11.81 |
| EV / FCF | -16.15 |
Financial Position
The company has a current ratio of 5.71, with a Debt / Equity ratio of 2.84.
| Current Ratio | 5.71 |
| Quick Ratio | 5.02 |
| Debt / Equity | 2.84 |
| Total Debt / Capitalization | 73.93 |
| Cash Flow / Debt | -0.34 |
| Interest Coverage | -3.19 |
Financial Efficiency
Return on equity (ROE) is -1.6% and return on capital (ROIC) is -29.2%.
| Return on Equity (ROE) | -1.6% |
| Return on Assets (ROA) | -0.31% |
| Return on Capital (ROIC) | -29.2% |
| Revenue Per Employee | 355.55K |
| Profits Per Employee | -179.11K |
| Employee Count | 184 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 21.52% in the last 52 weeks. The beta is 1.8, so NeuroPace 's price volatility has been higher than the market average.
| Beta | 1.8 |
| 52-Week Price Change | 21.52% |
| 50-Day Moving Average | 8.17 |
| 200-Day Moving Average | 9.08 |
| Relative Strength Index (RSI) | 60.68 |
| Average Volume (20 Days) | 78.39K |
Income Statement
In the last 12 months, NeuroPace had revenue of $65.42M and earned -$32.96M in profits. Earnings per share was $-1.27.
| Revenue | 65.42M |
| Gross Profit | 48.12M |
| Operating Income | -27.17M |
| Net Income | -32.96M |
| EBITDA | -22.83M |
| EBIT | -27.17M |
| Earnings Per Share (EPS) | -1.27 |
Balance Sheet
The company has $18.06M in cash and $72.39M in debt, giving a net cash position of -$54.34M.
| Cash & Cash Equivalents | 18.06M |
| Total Debt | 72.39M |
| Net Cash | -54.34M |
| Retained Earnings | -503.81M |
| Total Assets | 96.30M |
| Working Capital | 67.81M |
Cash Flow
In the last 12 months, operating cash flow was -$19.70M and capital expenditures -$173.00K, giving a free cash flow of -$19.87M.
| Operating Cash Flow | -19.70M |
| Capital Expenditures | -173.00K |
| Free Cash Flow | -19.87M |
| FCF Per Share | -0.77 |
Margins
Gross margin is 73.56%, with operating and profit margins of -41.54% and -50.38%.
| Gross Margin | 73.56% |
| Operating Margin | -41.54% |
| Pretax Margin | -50.38% |
| Profit Margin | -50.38% |
| EBITDA Margin | -34.9% |
| EBIT Margin | -41.54% |
| FCF Margin | -30.38% |
Dividends & Yields
NPCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -11.53% |
| FCF Yield | -6.05% |
Analyst Forecast
The average price target for NPCE is $15, which is 36.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $15 |
| Price Target Difference | 36.2% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Scores
| Altman Z-Score | -4.4 |
| Piotroski F-Score | 2 |